In the case of WesternGeco Ltd. v. Ion Geophysical Corp., the U.S. Supreme Court reversed the Federal Circuit’s rule against extraterritorial lost profits for infringement of U.S. Patents. The Supreme Court ruled that 35 U.S.C. § 271(f), permits a patent owner to recover [...]
In a close 5-4 decision in SAS Institute Inc. v. Iancu, the Supreme Court found that the Patent Trial and Appeal Board’s previous practice of agreeing to review some challenged claims and deny review of others in America Invents Act patent reviews, is [...]
The America Invents Act created a new vehicle for challengers to attach patents: the Inter-Parties Reexamination or “IPR”. In the case of Oil States Energy Services LLC v. Greene’s Energy Group, LLC, Oil States contended that the newly created IPR was unconstitutional because [...]
Weide & Miller is listed among the best law firms in the United States by U.S. News. Weide & Miller is ranked Tier 1 for Patent Law and Patent Litigation for 2018.
Weide & Miller issued 87 patents in 2017, leading Nevada-based firms.
In the case of In re Brunetti, a panel of the Court of Appeals for the Federal Circuit reversed a finding of the Trademark Trial and Appeal Board, the panel determining the Lanham Act (trademark law) prohibition against registering immoral or scandalous trademarks [...]
A long-accepted rule in U.S. patent law was that to find direct infringement of a method claim, performance of all claimed steps must be attributable to a single entity. Under prior case law, the actions of a third party could only be attributed [...]
In accordance with 28 U.S.C. § 1400, a patent infringement suit may only be brought in a jurisdiction where the defendant resides or where the defendant has committed acts of infringement and has a regular and established place of business. For over two [...]
In the case of Fourth Estate Benefit Corp. v. Wall-Street.com LLC, et al., the Court of Appeals for the Eleventh Circuit deepened the split between the circuit courts on the issue of whether a copyright registration must be obtained by a plaintiff before [...]
In the case of Helsinn Healthcare SA v. Teva Pharmacueticals USA, Inc., the Court of Appeals for the Federal Circuit confirmed that the America Invents Act did not change the “on-sale bar” to patenting an invention. The Court confirmed that, as with the [...]